Early Goal-Directed Therapy: When to stop...
In his presentation concluding the EGDT session this afternoon, Mervyn Singer will delve into what many claim is the most important question related to Early Goal-Directed Therapy, and that is when to say, as a clinician, that enough is enough. In his discussion, Singer notes that the presentation's title is quite fitting "First do not harm: When to stop" as he attributes most major benefits in outcomes over the last two decades directly to doing less to the patient (i.e. less sedation; fluid; blood transfusion; catecholamine; nutrition; tidal volumes, etc.)
"Take-home message? Maintain or promptly restore adequate organ perfusion without causing iatrogenic harm." (Mervyn Singer)
Of course, Singer acknowledges that the challenge for EGDT is to do enough for the patient without overdoing it. It can be a fine line with regards to fluid loading, blood transfusion, catecholamine use, etc., and to target physiologically appropriate therapeutic endpoints. A 'personalised medicine' approach is more rational than a one-size-fits-all strategy, says Singer.
This session also includes presentations from other experts on EGDT in sepsis, high-risk surgical patients as well as discussions of timing of treatments and the use of less invasive devices.
16.10.2012 16:00-18:00 Barcelona
EARLY GOAL-DIRECTED THERAPY
<Back to the news list